▶주메뉴 바로가기
▶본문 바로가기
The ongoing tug-of-war between the South Korean government and medical professionals over the proposed increase in the number of medical students could have negative impacts on local drug companies’ revenues as well, industry sources said Tuesday. According to officials from local pharmaceutical ...
Korean biopharmaceuticals firm Celltrion announced Monday that its new autoimmune disease treatment Zymfentra has been launched in the US market. Zymfentra is a subcutaneous injection formulation of Celltrion's infliximab Remsima. In October last year, the US Food and Drug Administration approved ...
South Korean biopharmaceutical firm Celltrion said Monday its new autoimmune disease treatment, Zymfentra, has made a debut in the US market. Zymfentra, a subcutaneous injection formulation of Celltrion's infliximab Remsima, won approval from the US Food and Drug Administration last year for use o...
South Korean pharmaceutical giant Yuhan has decided to reinstate the chairperson and vice chairperson positions for the first time in 28 years, since Chairman Yeon Man-hee stepped down from his post in 1996. Yuhan shareholders approved changes to the articles of incorporation to reestablish the po...
Samsung Biologics is off to a promising start this year with two large-scale contract manufacturing deal signings in March alone. According to Samsung Biologics on Wednesday, the company recently inked a contract manufacturing deal with MSD Switzerland, worth some $71 million. The deal, set to exp...
South Korean health care tech company LuluMedic said Tuesday that it has partnered with Indian consulting firm SVA Solutions to promote its comprehensive insurance plans tailored for overseas workers. This initiative aims to meet the increasing demand from Korean companies to comply with the Serio...
CHA Biotech announced on Thursday that it achieved a historic milestone in its annual revenue for last year, marking a record-breaking consolidated revenue of 954 billion won ($715 million), a notable 13 percent increase from the previous year. The company also saw a significant improvement in ope...
Celltrion`s autoimmune disease treatment Zymfentra (Celltrion) Biopharmaceutical giant Celltrion announced Wednesday that the first batch of its new autoimmune disease treatment Zymfentra, also known as Remsima SC, has been shipped for its planned debut in the US next month. Zymfentra is the firs...
Merck’s immuno-oncology drug Keytruda, one of the best-selling drugs in the world, topped drug sales in Korea for the second consecutive year in 2023, according to market tracker IQVIA on Tuesday. Keytruda’s sales in Korea came to some 399 billion won ($300 million) in 2023, up 159 billion won f...
Kolmar Korea, a cosmetics original design manufacturer, said Thursday it has found a microbiome that can slow down skin aging induced by sun exposure for the first time, which could be a breakthrough innovation in the anti-aging skincare industry. Photoaging refers to the characteristic changes to...
Overseas biosimilar sales of Samsung Bioepis, a biosimilar developer under Samsung Group, reached an all-time high in 2023, according to its partner companies on Sunday. According to Samsung Bioepis’ US partners, Biogen and Organon, sales of Samsung Bioepis’ biosimilar products in overseas marke...
Samsung Electronics Chair and Samsung Group leader Lee Jae-yong on Friday visited the group’s biotech arm in Incheon, calling on executives and staff members to set higher goals after the unit posted all-time high earnings last year. At Samsung Biologics’ biopharmaceutical campus in the Songdo I...
LG Chem announced Thursday that the company will work together with food giant CJ CheilJedang to produce bio-based nylon, an eco-friendly alternative to traditional synthetic polymers. LG Chem said the two companies signed a heads of agreement on Wednesday to establish a joint venture that will pr...
Celltrion announced Tuesday that the company has submitted its application for marketing authorization to the European Medicines Agency for CT-P47, a biosimilar referencing Roche's Actemra. Roche's Actemra (tocilizumab) is approved for a wide range of uses, including rheumatoid arthritis, giant ce...
Samsung-LG rivalry renewed in all-in-one washer
[KH Explains] Will Kakao Bank secure footing in untapped Thai market?
Drugmakers feeling pinch from doctors’ walkout
LG Energy Solution makes breakthrough in battery lifespan
Hyundai Motor Group continues to rack up EV accolades
CJ CheilJedang showcases K-food innovations at US expo